Impact of consecutive subsidies policies on access to and use of medicines in Brazil - ISAUM-Br: final report

The project’s achievements resulted from the partnership between different sectors, knowledge and perspectives. Each partner’s input has been a fundamental piece of this puzzle. The research group faced several challenges throughout these three years of project development such as acquiring necessary data sets, organizing and preparing the analysis and analyzing and reporting the findings. Some of the strategies used to involve the key stakeholders in the field were workshops and meetings, engaging representatives from DAF (Department of Pharmaceuticals/ MoH), Fiocruz and the research team. These initiatives have been extremely successful in improving team engagement and project development. The presentation of preliminary results to the entire team brought great value to the project, allowing a better view of the goals achieved and redirecting some approaches. MoH Farmácia Popular managers were very participative and enthusiastic about all the possibilities to analyze data routinely collected and discussing the possibilities of using the indicators proposed by our project, such as the proportion of days covered (PDC) and the user’s profile. In terms of dissemination of the project´s findings, in July/August 2015, the entire research team participated in Brazil’s main conference on public health (ABRASCO Congress –, where the project’s results were presented in several oral sessions and in a round table. Additionally, the research team organized a course on interrupted time series aiming to promote capacity building towards the methodological approach used in the ISAUM‐Br project. In addition, the project team submitted its second paper “Trends in hypertension and diabetes medicines use following changes in patient cost sharing in the Farmácia Popular” to the Health Policy journal. This paper aims to describe and analyze the evolution of the proportion of days covered for oral hypoglycemic (HGM) and antihypertensive (AHTM) medicines in the Farmácia Popular program using the data from “Farmácia Popular is available here” (AFP)and focuses on level and trend change regarding two specific interventions within the program that happened between 2008 and 2012. Finally, we are now able to tell the story of the Farmácia Popular Program’s impact on access to medicines in Brazil from 2002 to 2013 and arrive at the end of the project feeling grateful for having achieved the research’s goals and objectives. More importantly, we firmly believe that the partnership built with the MoH will increase the likelihood of use of these results to improve the Farmácia Popular program and, as a consequence, increase access to medicines for the population in need. The Progress Report ‐ Year 3 consists of the following sessions: executive summary, background, methodological approaches, limitations, results, discussion, conclusions and next steps.
Emmerick, Isabel C. Martins, et al. Impact of consecutive subsidies policies on access to and use of medicines in Brazil - ISAUM-Br: final report. Rio de Janeiro: Fiocruz/ENSP/NAF. Rio de Janeiro, 2016. Relatório final
Data de publicação: 
Ano da Publicação: 
2 016